Associate/Sr. Associate, Business Development and Operations

Apply Now

Company

QED Therapeutics

Location

San Francisco, California

Who we are

A subsidiary of BridgeBio Pharma, QED focuses on precision medicine for FGFR-driven cancers and diseases. Our lead investigational candidate is infigratinib, an orally administered FGFR1-3 tyrosine kinase inhibitor that has shown meaningful clinical activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and metastatic urothelial carcinoma with FGFR3 genomic alterations. We are also evaluating infigratinib for the treatment of achondroplasia and other skeletal dysplasias. 

QED is derived from the Latin “Quod Erat Demonstrandum” —Thus, It Has Been Proven. Our business is inspired by our values:

  • PUT PATIENTS FIRST
  • LET SCIENCE SPEAK
  • ACT NIMBLY
  • THINK INDEPENDENTLY
  • BE RADICALLY TRANSPARENT

The Opportunity:

QED is expanding its business development and operations team and is seeking a teammate who will assist in our worldwide launch, partnership development, and corporate strategy. In this unique role you will be supporting the strategy and execution of partnership transactions, as well as generating analysis to support decision-making across the organization.  You will be able to directly see the impact your work is having on getting infigratinib to patients.

The Role:

The Associate/Senior Associate, Business Development and Operations will be an integral part of the business development and operations group. The position is likely to support a wide variety of projects, including:

  • Partnering with other companies around the world to ensure that infigratinib can be accessed by patients worldwide
  • Conducting analysis to support the commercial launch of infigratinib
  • Supporting the clinical development of infigratinib, including the execution of our two Phase 3 trials in oncology and additional clinical studies in oncology and rare, genetically-driven diseases
  • Gathering and synthesizing preclinical and clinical data on infigratinib and competitor molecules to generate competitive intelligence
  • Performing other strategic analyses as needed by the company and acting as a strategic partner to cross-functional teams
  • Discussing findings of relevant strategic analyses with the QED Executive Team, the QED Board of Directors, and investors

Qualifications:

The successful candidate should possess proven scientific acumen, communication skills, and an analytical mindset.  Experience working in the life sciences is strongly preferred.  You should also have:

  • A passion for helping patients
  • Education in a life science discipline including an advanced degree or equivalent work experience
  • Prior management consulting or biopharma industry experience (preferred)
  • Demonstrated ability to solve problems using a structured, analytical approach
  • Familiarity with the drug discovery & development process
  • Exceptional written communication and presentation skills
  • A ‘self-starter’ attitude
careers

Associate/Sr. Associate, Business Development and Operations

Apply Now